GNLX

NASDAQ · Equity

Genelux Corporation Common Stock

US Healthcare Biotechnology

Latest week
29 May 2026
Close
3.050000
Fair value
7.244679
Expectation
Undecided 45.94%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
3.05
12-Week Change
17.31%
Trend Signal
Inactive
Expectation
Undecided 45.94%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-31.72
Market Dynamics
0.58

Over the latest 12 completed weeks ending 2026-05-29, GNLX rose 17.31%, moving from 2.60 to 3.05. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -31.72 and has softened across the 12-week window. Market Dynamics is 0.58 on the latest week. Expectation is undecided at 45.94%.